Cytogenetic characterization of several androgen responsive and unresponsive sublines of the human prostatic carcinoma cell line LNCaP
- PMID: 2734981
- DOI: 10.1007/BF00262025
Cytogenetic characterization of several androgen responsive and unresponsive sublines of the human prostatic carcinoma cell line LNCaP
Abstract
The cytogenetic evolution of the prostatic adenocarcinoma cell line LNCaP was investigated during long term in vitro culture. Study of five different sublines demonstrated that the original karyotype was well preserved in all sublines, with respect to the chromosome number as well as to the primary markers. All sublines showed additional, subline specific secondary marker chromosomes. Comparison of these markers in androgen responsive and nonresponsive sublines showed rearrangement of the short arm of chromosome 8 in both unresponsive sublines. The breakpoints were in 8p21 and 8p23, respectively, resulting in deletion of the 8p23----pter region in both sublines. In contrast, the hormone responsive sublines did not show any aberrations in chromosome 8. Review of published karyotypes of patients and cell lines seems to support our finding of partial deletion of 8p in androgen unresponsive prostate tumor cells.
Similar articles
-
Characterization of chromosome 8 aberrations in the prostate cancer cell line LNCaP-FGC and sublines.Urol Res. 1999;27(1):3-8. doi: 10.1007/s002400050082. Urol Res. 1999. PMID: 10092147 Review.
-
Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells.Int J Cancer. 1994 May 1;57(3):406-12. doi: 10.1002/ijc.2910570319. Int J Cancer. 1994. PMID: 8169003
-
The human prostatic carcinoma cell line LNCaP and its derivatives. An overview.Urol Res. 1989;17(2):71-7. doi: 10.1007/BF00262024. Urol Res. 1989. PMID: 2660395 Review.
-
A novel human prostate-specific, androgen-regulated homeobox gene (NKX3.1) that maps to 8p21, a region frequently deleted in prostate cancer.Genomics. 1997 Jul 1;43(1):69-77. doi: 10.1006/geno.1997.4715. Genomics. 1997. PMID: 9226374
-
A high-resolution study of chromosome changes in a human prostatic carcinoma cell line (LNCaP).Cancer Genet Cytogenet. 1984 Apr;11(4):399-404. doi: 10.1016/0165-4608(84)90020-7. Cancer Genet Cytogenet. 1984. PMID: 6584201
Cited by
-
Differential sensitivity of hormone-responsive and unresponsive human prostate cancer cells (LNCaP) to tumor necrosis factor.Urol Res. 1992;20(3):193-7. doi: 10.1007/BF00299716. Urol Res. 1992. PMID: 1615580
-
LNCaP-OM, a new androgen-resistant prostate cancer subline.In Vitro Cell Dev Biol Anim. 1997 Mar;33(3):147-9. doi: 10.1007/s11626-997-0131-1. In Vitro Cell Dev Biol Anim. 1997. PMID: 9112118 No abstract available.
-
Periprostatic adipose tissue inhibits tumor progression by secreting apoptotic factors: A natural barrier induced by the immune response during the early stages of prostate cancer.Oncol Lett. 2024 Aug 8;28(4):485. doi: 10.3892/ol.2024.14617. eCollection 2024 Oct. Oncol Lett. 2024. PMID: 39170882 Free PMC article.
-
Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system.Br J Cancer. 1999 Sep;81(2):242-51. doi: 10.1038/sj.bjc.6690684. Br J Cancer. 1999. PMID: 10496349 Free PMC article.
-
The Genomics of Prostate Cancer: A Historic Perspective.Cold Spring Harb Perspect Med. 2019 Mar 1;9(3):a034942. doi: 10.1101/cshperspect.a034942. Cold Spring Harb Perspect Med. 2019. PMID: 29712681 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials